Strain-specific mammary proliferative lesion development following lifetime oral administration of ochratoxin A in DA and Lewis rats
✍ Scribed by Woo-Chan Son; Kenji Kamino; Yong-Soon Lee; Kyung-Sun Kang
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 297 KB
- Volume
- 105
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
OTA, a potent nephrotoxin in several species, is a renal carcinogen in animals and is implicated in the etiology of BEN. The NTP classified OTA as having clear evidence of carcinogenic activity, based on uncommon tubular adenomas and tubular cell carcinomas of the kidney and multiple fibroadenomas of the mammary gland, seen in the rat. As shown previously (Castegnaro et al., Int J Cancer 1998;77:70–5), induction of renal tumors by OTA is sex‐ and strain‐specific in DA and Lewis rats, with DA males being most responsive and DA females being resistant; however, that report was confined to the kidney and urinary tract. To obtain OTA‐induced tumorigenic information in rats, we administered OTA (0.4 mg/kg) by oral gavage to both DA and Lewis rats for their lifetimes and extended the investigation to complete histopathology of all tissues and organs. We also observed the characteristic renal tumor that is highly strain‐ and sex‐specific, and there were increased incidences of proliferative mammary lesions in Lewis rats but not in DA rats, indicating that these were also strain‐specific. In view of the NTP report of OTA treatment‐related mammary fibroadenoma in F344 rats, we observed increased mammary proliferative lesions in Lewis rats but not in DA rats. Our results suggest that OTA may play some role in mammary tumor development in some rat strains. © 2003 Wiley‐Liss, Inc.